| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cibus, Inc. (CBUS) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CBUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 14.58M | $21.00M | - | |
| CEO | 686.8K | $989.0K | - | |
| Other | 167.9K | $241.7K | - | |
| VP | 139.9K | $201.4K | - | |
| CFO | 114.0K | $164.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 13, 2025 | Sauer Noel | Sr VP, Research | Sell | 4 | $1.49 | $5.94 | - | -5.7% | - | |
| Feb 25, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $1.92 | $2,208.00 | -13.0% | +45.4% | +90.3% | |
| Feb 24, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.07 | $2,380.50 | -11.5% | +48.8% | +92.7% | |
| Feb 21, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.20 | $2,530.00 | -10.3% | +33.2% | +43.8% | |
| Feb 20, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.35 | $2,702.50 | -9.3% | +27.3% | +38.4% | |
| Feb 19, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.58 | $2,967.00 | -8.5% | +21.5% | +28.2% | |
| Feb 18, 2025 | Prante Gerhard78 | Director | Sell | 2,300 | $2.52 | $5,796.00 | -7.6% | +19.5% | +19.5% | |
| Feb 14, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.60 | $2,990.00 | -6.8% | +3.6% | -9.1% | |
| Feb 13, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.53 | $2,909.50 | -6.4% | -16.6% | -11.2% | |
| Feb 12, 2025 | Prante Gerhard78 | Director | Sell | 1,150 | $2.45 | $2,817.50 | -6.0% | -8.7% | -21.3% |